SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : TGL WHAAAAAAAT! Alerts, thoughts, discussion.
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: TomNY who wrote (68225)10/24/2000 8:54:11 AM
From: Theo  Read Replies (1) of 150070
 
Without knowing the details of the " Other terms of the agreement were not disclosed." disclaimer, I still have to say that for ORCH to embrace the "pinky" DNAP is a huge milestone for DNAPrint. Of course, in reciprocation, ORCH has access to the "brain trust" that DNAP has put together as well. Although several RB posts/posters have begun postulating hypothetical outcomes with ORCH essentially taking control of DNAP via revenue or equity considerations, I personally see nothing wrong with either scenario from a shareholder stand point. Royalties or outright ownership- I, as a shareholder, still make money, but, I/we are getting WAY ahead of the program here as I suspect that ORCH is NOT the only entity looking at DNAP...:):) ORCH did not lash itself to a, as yet, non-reporting company- no, instead, as they put it, they purchased the option that gives them " the potential opportunity to partner with DNAPrint genomics," said Russell Granzow,..."

Huge potential here IMHO!
Theo;-)
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News